BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 32394903)

  • 1. Proton-pump inhibitors and chronic kidney disease: Hidden consequences of an inappropriate drug use?
    Schiffl H; Al-Nemnem E; Lang SM
    Saudi J Kidney Dis Transpl; 2020; 31(2):312-319. PubMed ID: 32394903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Association Between Proton Pump Inhibitor Use With Acute Kidney Injury and Chronic Kidney Disease.
    Kamal F; Khan MA; Molnar MZ; Howden CW
    J Clin Gastroenterol; 2018 Jul; 52(6):468-476. PubMed ID: 29668562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PPIs and kidney disease: from AIN to CKD.
    Moledina DG; Perazella MA
    J Nephrol; 2016 Oct; 29(5):611-6. PubMed ID: 27072818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proton Pump Inhibitors and Risk of Acute and Chronic Kidney Disease: A Retrospective Cohort Study.
    Hart E; Dunn TE; Feuerstein S; Jacobs DM
    Pharmacotherapy; 2019 Apr; 39(4):443-453. PubMed ID: 30779194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship between proton pump inhibitors and renal disease.
    Morschel CF; Mafra D; Eduardo JCC
    J Bras Nefrol; 2018; 40(3):301-306. PubMed ID: 30010692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Proton pump inhibitors and kidney].
    Desbuissons G; Deray G; Mercadal L
    Nephrol Ther; 2018 Apr; 14 Suppl 1():S115-S124. PubMed ID: 29274872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proton pump inhibitors and traditional nonsteroidal anti-inflammatory drugs and the risk of acute interstitial nephritis and acute kidney injury.
    Leonard CE; Freeman CP; Newcomb CW; Reese PP; Herlim M; Bilker WB; Hennessy S; Strom BL
    Pharmacoepidemiol Drug Saf; 2012 Nov; 21(11):1155-72. PubMed ID: 22887960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association between proton pump inhibitor use and the risk of adverse kidney outcomes: a systematic review and meta-analysis.
    Nochaiwong S; Ruengorn C; Awiphan R; Koyratkoson K; Chaisai C; Noppakun K; Chongruksut W; Thavorn K
    Nephrol Dial Transplant; 2018 Feb; 33(2):331-342. PubMed ID: 28339835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proton pump inhibitors associated acute kidney injury and chronic kidney disease: data mining of US FDA adverse event reporting system.
    Wu B; Li D; Xu T; Luo M; He Z; Li Y
    Sci Rep; 2021 Feb; 11(1):3690. PubMed ID: 33574396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association of proton pump inhibitors and chronic kidney disease: cause or confounding?
    Li T; Xie Y; Al-Aly Z
    Curr Opin Nephrol Hypertens; 2018 May; 27(3):182-187. PubMed ID: 29432214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term kidney outcomes among users of proton pump inhibitors without intervening acute kidney injury.
    Xie Y; Bowe B; Li T; Xian H; Yan Y; Al-Aly Z
    Kidney Int; 2017 Jun; 91(6):1482-1494. PubMed ID: 28237709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proton pump inhibitors and acute interstitial nephritis.
    Geevasinga N; Coleman PL; Webster AC; Roger SD
    Clin Gastroenterol Hepatol; 2006 May; 4(5):597-604. PubMed ID: 16630752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proton pump inhibitors and the kidney: critical review.
    Brewster UC; Perazella MA
    Clin Nephrol; 2007 Aug; 68(2):65-72. PubMed ID: 17722704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proton Pump Inhibitors and the Kidney: Implications of Current Evidence for Clinical Practice and When and How to Deprescribe.
    Al-Aly Z; Maddukuri G; Xie Y
    Am J Kidney Dis; 2020 Apr; 75(4):497-507. PubMed ID: 31606235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complications of Proton Pump Inhibitor Therapy.
    Vaezi MF; Yang YX; Howden CW
    Gastroenterology; 2017 Jul; 153(1):35-48. PubMed ID: 28528705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biopsy-proven acute interstitial nephritis, 1993-2011: a case series.
    Muriithi AK; Leung N; Valeri AM; Cornell LD; Sethi S; Fidler ME; Nasr SH
    Am J Kidney Dis; 2014 Oct; 64(4):558-66. PubMed ID: 24927897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations of Proton-Pump Inhibitors and H2 Receptor Antagonists with Chronic Kidney Disease: A Meta-Analysis.
    Wijarnpreecha K; Thongprayoon C; Chesdachai S; Panjawatanana P; Ungprasert P; Cheungpasitporn W
    Dig Dis Sci; 2017 Oct; 62(10):2821-2827. PubMed ID: 28836158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proton Pump Inhibitor Use and the Risk of Chronic Kidney Disease.
    Lazarus B; Chen Y; Wilson FP; Sang Y; Chang AR; Coresh J; Grams ME
    JAMA Intern Med; 2016 Feb; 176(2):238-46. PubMed ID: 26752337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of postmarketing safety data for proton-pump inhibitors reveals increased propensity for renal injury, electrolyte abnormalities, and nephrolithiasis.
    Makunts T; Cohen IV; Awdishu L; Abagyan R
    Sci Rep; 2019 Feb; 9(1):2282. PubMed ID: 30783195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proton pump inhibitor use and progression to major adverse renal events: a competing risk analysis.
    Grant CH; Gillis KA; Lees JS; Traynor JP; Mark PB; Stevens KI
    QJM; 2019 Nov; 112(11):835-840. PubMed ID: 31251364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.